Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
3.270
+0.060 (1.87%)
Nov 5, 2024, 3:43 PM EST - Market open

Phio Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-8.68-10.83-11.48-13.29-8.79-8.91
Upgrade
Depreciation & Amortization
0.130.180.190.190.070.07
Upgrade
Loss (Gain) From Sale of Assets
0-----
Upgrade
Asset Writedown & Restructuring Costs
0.130.13----
Upgrade
Stock-Based Compensation
0.150.30.410.480.140.3
Upgrade
Other Operating Activities
----0.230.110.11
Upgrade
Change in Accounts Payable
-0.31-0.120.5-0.45-0.080.26
Upgrade
Change in Other Net Operating Assets
-0.48-0.41-1.751.44-0.25-0.47
Upgrade
Operating Cash Flow
-9.06-10.75-12.13-11.86-8.8-8.65
Upgrade
Capital Expenditures
--0.01-0.12-0.05-0.02-0.07
Upgrade
Investing Cash Flow
--0.01-0.12-0.05-0.02-0.07
Upgrade
Long-Term Debt Issued
----0.23-
Upgrade
Long-Term Debt Repaid
-----0.03-0.01
Upgrade
Net Debt Issued (Repaid)
----0.2-0.01
Upgrade
Issuance of Common Stock
2.47.45-21.7215.940.78
Upgrade
Repurchase of Common Stock
-0.01-0.04-0.03-0-0.02-0
Upgrade
Financing Cash Flow
2.47.41-0.0321.7216.130.77
Upgrade
Net Cash Flow
-6.66-3.34-12.289.817.31-7.95
Upgrade
Free Cash Flow
-9.06-10.75-12.25-11.91-8.82-8.72
Upgrade
Free Cash Flow Margin
------41509.52%
Upgrade
Free Cash Flow Per Share
-22.29-46.45-97.00-100.24-207.68-
Upgrade
Cash Interest Paid
----0.010.01
Upgrade
Levered Free Cash Flow
-5.73-6.53-7.81-6.71-5.55-5.39
Upgrade
Unlevered Free Cash Flow
-5.73-6.53-7.81-6.71-5.55-5.39
Upgrade
Change in Net Working Capital
0.630.371.13-1.110.250.07
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.